Tower Research Capital LLC (Trc) Takeda Pharmaceutical CO LTD Transaction History

Tower Research Capital LLC (Trc)

$3.53 Billion
Q2 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 26,300 shares of TAK stock, worth $379,772. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,300

Previous 12,600 108.73%

Holding current value

$379,772

Previous $187,000 117.11%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$13.71 - $15.46 $187,827 - $211,802	13,700 Added 108.73%	26,300 $406,000
Q1 2025 May 15, 2025	SELL	$12.89 - $15.19 $106,961 - $126,046	-8,298 Reduced 39.71%	12,600 $187,000
Q4 2024 Feb 13, 2025	BUY	$13.01 - $14.43 $218,906 - $242,799	16,826 Added 413.21%	20,898 $276,000
Q3 2024 Nov 14, 2024	SELL	$13.0 - $15.08 $31,473 - $36,508	-2,421 Reduced 37.29%	4,072 $57,000
Q2 2024 Aug 13, 2024	BUY	$12.6 - $13.67 $65,935 - $71,535	5,233 Added 415.32%	6,493 $84,000
Q1 2024 May 15, 2024	SELL	$13.89 - $15.04 $76,256 - $82,569	-5,490 Reduced 81.33%	1,260 $17,000
Q4 2023 Feb 13, 2024	BUY	$13.36 - $15.43 $61,803 - $71,379	4,626 Added 217.8%	6,750 $96,000
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $3,637 - $3,949	-242 Reduced 10.23%	2,124 $32,000
Q2 2023 Aug 14, 2023	SELL	$15.57 - $17.11 $7,317 - $8,041	-470 Reduced 16.57%	2,366 $37,000
Q1 2023 May 09, 2023	BUY	$15.28 - $16.48 $8,052 - $8,684	527 Added 22.82%	2,836 $47,000
Q4 2022 Feb 10, 2023	BUY	$12.42 - $15.62 $28,677 - $36,066	2,309 New	2,309 $36,000
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $107,374 - $123,005	8,184 Added 218.01%	11,938 $168,000
Q1 2022 May 12, 2022	BUY	$13.54 - $15.35 $50,829 - $57,623	3,754 New	3,754 $54,000
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $165,689 - $175,447	-10,165 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $228,555 - $257,418	-13,810 Reduced 57.6%	10,165 $171,000
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $397,280 - $473,122	23,775 Added 11887.5%	23,975 $438,000
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $6,925 - $8,536	-450 Reduced 69.23%	200 $4,000
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $30,643 - $34,388	-1,792 Reduced 73.38%	650 $12,000
Q2 2020 Aug 13, 2020	BUY	$14.59 - $19.5 $35,409 - $47,326	2,427 Added 16180.0%	2,442 $44,000
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $135,355 - $211,142	-10,396 Reduced 99.86%	15 $0
Q4 2019 Feb 07, 2020	BUY	$16.88 - $20.83 $175,737 - $216,861	10,411 New	10,411 $205,000
Q3 2019 Nov 05, 2019	SELL	$16.15 - $17.99 $30,652 - $34,145	-1,898 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$16.58 - $20.49 $30,805 - $38,070	1,858 Added 4645.0%	1,898 $34,000
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $668 - $860	40 New	40 $1,000

Others Institutions Holding TAK

# of Institutions

370

Shares Held

73M

Call Options Held

1.68M

Put Options Held

157K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.9B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Takeda Pharmaceutical CO LTD Transaction History